What side effects are associated with this type of intervention?

Contingency Management (CM) for electronic cigarette use typically has minimal physical side effects, as it primarily involves providing rewards for positive behavior. However, it may lead to dependency on external rewards for motivation. Cognitive Behavioral Therapy (CBT) is generally well-tolerated, but some individuals may experience increased anxiety or emotional discomfort as they confront and work through challenging thoughts and behaviors. Both treatments are considered safe and effective for addressing electronic cigarette use.

What prior FDA approvals exist?

As of now, there are no specific FDA-approved treatments exclusively for electronic cigarette use. However, treatments for smoking cessation that may be applicable include Nicotine Replacement Therapy (NRT), varenicline, and bupropion, which are FDA-approved for traditional cigarette cessation. Behavioral therapies such as Cognitive Behavioral Therapy (CBT) and Contingency Management (CM) have shown efficacy in smoking cessation and are being studied for their potential in treating electronic cigarette use. These therapies focus on addressing psychological aspects, developing coping strategies, and reinforcing positive behavior through rewards.

What other types of research exist?

Promising novel alternatives to CM and CBT for electronic cigarette use patients include: 1) Mobile phone-based interventions, such as apps that provide real-time monitoring and notifications, which have shown effectiveness in smoking reduction. 2) Text messaging interventions, which offer personalized, automated motivational messages and have been effective in increasing abstinence rates. 3) Internet-based interventions, including social network-based programs like Tweet2Quit and Facebook interventions, which leverage social support for smoking cessation. 4) Acceptance and Commitment Therapy (ACT), delivered face-to-face or by telephone, which focuses on psychological flexibility and has shown effectiveness in smoking cessation.

← Back to Search

Behavioral Intervention

Contingency Management + Cognitive Behavioral Therapy for Quitting Vaping

N/A

Recruiting

Led By Suchitra Krishnan-Sarin, PhD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Must not have

Current diagnosis of psychosis or evidence of significant homicidal/suicidal risk

Current diagnosis of a significant mental health disorder that is not being treated by a mental health practitioner with either behavioral and/or pharmacological interventions

Timeline

Screening 3 weeks

Treatment Varies

Follow Up end of treatment at week 4, 1, 3, 6, and 12 month

Summary

This trial aims to help teenagers who vape quit by using rewards and online counseling. The program targets teens aged 13-19 who want to stop vaping. It works by giving rewards for not vaping and providing counseling to change their behavior and thoughts about vaping.

Who is the study for?

This trial is for high school students aged 13-19 who regularly use e-cigarettes with nicotine and want to quit. They must be able to read and write, have no major mental health issues untreated, not use psychoactive drugs or antidepressants unless stable and monitored, not pregnant or lactating, and without substance dependence except mild cannabis use.

What is being tested?

The study tests a new program combining rewards (contingency management) with online video counseling (cognitive behavioral therapy) to help teenagers stop vaping. Participants will either receive this intervention or be in a control group that does not receive the treatment.

What are the potential side effects?

Since the interventions are behavioral therapies involving rewards and counseling sessions, there are no direct medical side effects like those from medication. However, participants may experience stress or anxiety related to quitting nicotine.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have psychosis or a high risk of harming myself or others.

Select...

I have an untreated significant mental health condition.

Select...

I am currently pregnant or breastfeeding.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ end of treatment at week 4, 1, 3, 6, and 12 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~end of treatment at week 4, 1, 3, 6, and 12 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and end of treatment at week 4, 1, 3, 6, and 12 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in 7-day point prevalence abstinence

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Remote Contingency Management (CM) for nicotine abstinenceExperimental Treatment1 Intervention

Participants will be paid increasing amounts of payment for each negative saliva cotinine test.

Group II: ControlPlacebo Group1 Intervention

Participants will be paid for providing saliva nicotine test, regardless of whether the test is positive or negative.

0 / 3Eligibility criteria met

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

The most common treatments for Electronic Cigarette Use include Contingency Management (CM) and Cognitive Behavioral Therapy (CBT). CM reinforces positive behavior through rewards, providing tangible incentives for patients to quit vaping. CBT addresses the psychological aspects of addiction, helping patients develop coping strategies to manage cravings and triggers. This dual approach is effective for Electronic Cigarette Use patients as it combines motivation through rewards with essential psychological tools for maintaining long-term abstinence.